Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies
Go back to Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies| AGENUS (NASDAQ: AGEN) | Delayed: 7.81 -0.44 (5.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.25 | 52 Week High | $7.49 | |||
| Open | $8.28 | 52 Week Low | $2.61 | |||
| Day High | $8.52 | P/E | N/A | |||
| Day Low | $7.78 | EPS | $-1.10 | |||
| Volume | 782,651 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 148.86 +0.77 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.09 | 52 Week High | $108.63 | |||
| Open | $147.30 | 52 Week Low | $71.39 | |||
| Day High | $149.11 | P/E | 82.24 | |||
| Day Low | $146.01 | EPS | $1.81 | |||
| Volume | 4,981,343 | |||||
